Disease-modifying therapies for MS that prevent brain volume loss are linked to reduced long-term disability, new data show.
Taking lipoic acid failed to ease progressive MS symptoms in a clinical trial, but the antioxidant showed signs of slowing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback